These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles. Hashimoto K, Watanabe K, Mitsuhashi H. Cardiovasc Drugs Ther; 1989 Oct; 3(5):683-9. PubMed ID: 2488108 [Abstract] [Full Text] [Related]
9. Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations. Sugiyama A, Takehana S, Kimura R, Hashimoto K. Heart Vessels; 1999 Dec; 14(2):96-103. PubMed ID: 10651186 [Abstract] [Full Text] [Related]
10. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias. Hashimoto K, Ishii M, Komori S. J Cardiovasc Pharmacol; 1984 Dec; 6(2):213-9. PubMed ID: 6200706 [Abstract] [Full Text] [Related]
11. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs. Chen J, Xue Y, Eto K, Ni C, Hashimoto K. J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885 [Abstract] [Full Text] [Related]
12. Cardiovascular and antiarrhythmic effects of the azulene-1-carboxamidine derivative N1,N1-dimethyl-N2-(2-pyridylmethyl)-5-isopropyl-3, 8-dimethylazulene-1-carboxamidine. Saitoh M, Sugiyama A, Hagihara A, Nakazawa T, Hashimoto K. Arzneimittelforschung; 1997 Jul; 47(7):810-5. PubMed ID: 9272236 [Abstract] [Full Text] [Related]
13. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia. Haruno A, Hashimoto K. Eur J Pharmacol; 1993 Mar 16; 233(1):1-6. PubMed ID: 8472737 [Abstract] [Full Text] [Related]
14. Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models. Mitsuhashi H, Akiyama K, Hashimoto K, Sawa Y, Hatori Y. Jpn J Pharmacol; 1987 Jun 16; 44(2):155-62. PubMed ID: 3656773 [Abstract] [Full Text] [Related]
15. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias. Hashimoto K, Akiyama K, Mitsuhashi H. Jpn J Pharmacol; 1989 Feb 16; 49(2):245-54. PubMed ID: 2733262 [Abstract] [Full Text] [Related]
16. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Hashimoto K, Haruno A, Matsuzaki T, Sugiyama A, Akiyama K. Cardiovasc Drugs Ther; 1991 Aug 16; 5 Suppl 4():805-17. PubMed ID: 1657110 [Abstract] [Full Text] [Related]
17. Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models. Akiyama K, Hashimoto K. Jpn Heart J; 1989 Jul 16; 30(4):487-95. PubMed ID: 2509760 [Abstract] [Full Text] [Related]
18. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models. Xue Y, Tanabe S, Nabuchi Y, Hashimoto K. J Cardiovasc Pharmacol; 1998 Aug 16; 32(2):239-47. PubMed ID: 9700986 [Abstract] [Full Text] [Related]
19. Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations. Hashimoto K, Shibuya T, Satoh H, Imai S. Jpn Circ J; 1983 Jan 16; 47(1):92-7. PubMed ID: 6827775 [Abstract] [Full Text] [Related]
20. Synthesis and antiarrhythmic activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines. Kumazawa T, Harakawa H, Obase H, Oiji Y, Nito M, Kubo K, Ishii A, Tomioka S, Yamada Y. J Med Chem; 1990 Nov 16; 33(11):3095-100. PubMed ID: 2231611 [Abstract] [Full Text] [Related] Page: [Next] [New Search]